149 related articles for article (PubMed ID: 32927237)
1. Self-reported symptoms among participants in a population-based screening program.
Larsen M; Lilleborge M; Vigeland E; Hofvind S
Breast; 2020 Dec; 54():56-61. PubMed ID: 32927237
[TBL] [Abstract][Full Text] [Related]
2. Rate of breast cancer diagnoses among postmenopausal women with self-reported breast symptoms.
Aiello EJ; Buist DS; White E; Seger D; Taplin SH
J Am Board Fam Pract; 2004; 17(6):408-15. PubMed ID: 15575032
[TBL] [Abstract][Full Text] [Related]
3. Participation and cancer detection after reminders versus ordinary invitations in BreastScreen Norway.
Thy JE; Vigeland E; Larsen M; Hofvind S
J Med Screen; 2022 Sep; 29(3):178-184. PubMed ID: 35502849
[TBL] [Abstract][Full Text] [Related]
4. Early performance measures following regular versus irregular screening attendance in the population-based screening program for breast cancer in Norway.
Thy JE; Larsen M; Vigeland E; Koch H; Hovda T; Hofvind S
J Med Screen; 2024 Jun; 31(2):107-114. PubMed ID: 37691575
[TBL] [Abstract][Full Text] [Related]
5. Risk of breast cancer by prior screening results among women participating in BreastScreen Norway.
Lilleborge M; Falk RS; Russnes H; Sauer T; Ursin G; Hofvind S
Cancer; 2019 Oct; 125(19):3330-3337. PubMed ID: 31206638
[TBL] [Abstract][Full Text] [Related]
6. Screening at stationary versus mobile units in BreastScreen Norway.
Holen Å; Sebuødegård S; Waade GG; Aase H; Hopland NM; Pedersen K; Larsen M; Tsuruda KM; Hofvind S
J Med Screen; 2020 Mar; 27(1):31-39. PubMed ID: 31554445
[TBL] [Abstract][Full Text] [Related]
7. Early screening outcomes among non-immigrants and immigrants targeted by BreastScreen Norway, 2010-2019.
Thy JE; Bhargava S; Larsen M; Akslen LA; Hofvind S
Scand J Public Health; 2023 May; 51(3):403-411. PubMed ID: 35361004
[TBL] [Abstract][Full Text] [Related]
8. Cancer incidence and mortality patterns in women with breast symptoms in the mammography screening programme: A matched cohort analysis.
Singh D; Malila N; Pitkäniemi J; Anttila A
Int J Cancer; 2019 Jun; 144(12):2928-2935. PubMed ID: 30511466
[TBL] [Abstract][Full Text] [Related]
9. Screen-detected and interval breast cancer after concordant and discordant interpretations in a population based screening program using independent double reading.
Martiniussen MA; Sagstad S; Larsen M; Larsen ASF; Hovda T; Lee CI; Hofvind S
Eur Radiol; 2022 Sep; 32(9):5974-5985. PubMed ID: 35364710
[TBL] [Abstract][Full Text] [Related]
10. Reported breast symptoms in the National Breast and Cervical Cancer Early Detection Program.
Ryerson AB; Miller J; Eheman CR
Cancer Causes Control; 2015 May; 26(5):733-40. PubMed ID: 25754109
[TBL] [Abstract][Full Text] [Related]
11. BreastScreen-based mammography screening in women with a personal history of breast cancer, Western Australian study.
Houssami N; Tresham JJ; Fritschi L; Wylie LE
Med J Aust; 2011 Oct; 195(8):460-4. PubMed ID: 22004397
[TBL] [Abstract][Full Text] [Related]
12. Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening program.
Hovda T; Brandal SHB; Sebuødegård S; Holen ÅS; Bjørndal H; Skaane P; Hofvind S
Eur Radiol; 2019 Dec; 29(12):6991-6999. PubMed ID: 31187221
[TBL] [Abstract][Full Text] [Related]
13. Mammographic features and risk of breast cancer death among women with invasive screen-detected cancer in BreastScreen Norway 1996-2020.
Moshina N; Backmann HA; Skaane P; Hofvind S
Eur Radiol; 2024 May; 34(5):3364-3374. PubMed ID: 37935848
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Rurality and Disadvantage on the Diagnostic Interval for Breast Cancer in a Large Population-Based Study of 3202 Women in Queensland, Australia.
Youl PH; Aitken JF; Turrell G; Chambers SK; Dunn J; Pyke C; Baade PD
Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27869758
[TBL] [Abstract][Full Text] [Related]
15. Association of symptoms and breast cancer in population-based mammography screening in Finland.
Singh D; Malila N; Pokhrel A; Anttila A
Int J Cancer; 2015 Mar; 136(6):E630-7. PubMed ID: 25160029
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
17. Performance measures among non-immigrants and immigrants attending BreastScreen Norway: a population-based screening programme.
Bhargava S; Akslen LA; Bukholm IRK; Hofvind S
Eur Radiol; 2019 Sep; 29(9):4833-4842. PubMed ID: 30762109
[TBL] [Abstract][Full Text] [Related]
18. Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.
Niraula S; Biswanger N; Hu P; Lambert P; Decker K
JAMA Netw Open; 2020 Sep; 3(9):e2018179. PubMed ID: 32975573
[TBL] [Abstract][Full Text] [Related]
19. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
20. Risk of breast cancer in symptomatic women in primary care: a case-control study using electronic records.
Walker S; Hyde C; Hamilton W
Br J Gen Pract; 2014 Dec; 64(629):e788-93. PubMed ID: 25452544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
